Literature DB >> 454641

Short chain ceramides as substrates for glucocerebroside synthetase. Differences between liver and brain enzymes.

R R Vunnam, N S Radin.   

Abstract

In order to increase the sensitivity of the assay for ceramide: UDPGlc glucosyltransferase, the enzyme that makes glucocerebroside, we synthesized a variety of ceramide homologues that might be better substrates than the naturally occurring ceramides. N-Octanoyl sphingosine proved to be the best lipid tested in liver and brain. It could be added to the tissue homogenate in the dry form, as a thin layer coated on Celite, or in liposomes, prepared from lecithin and cerebroside sulfate. The liposomal form produced better replication of assay values. It is suggested that the addition of cerebroside sulfate to liposomal preparations might be a good, and more physiological, replacement for the commonly used dicetyl phosphate. A new homologue of DL-sphinganine, decasphinganine, was synthesized by an efficient series of steps and acylated with different fatty acids to form ceramide homologues. The best substrate in this series was the lauroyl amide and it is suggested that this lipid be used in cerebroside synthetase assays because of the convenience of preparing it, even though it is not as good as octanoyl sphingosine. Both compounds are distinctly better than natural ceramide or DL-sphinganine amides. From comparisons of enzyme activity under various conditions, the tentative conclusion is drawn that the enzymes in liver and brain have different properties, and that liver has two different synthetases.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 454641     DOI: 10.1016/0005-2760(79)90174-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  A simple method for the synthesis of ceramides and radiolabeled analogues.

Authors:  J K Anand; K K Sadozai; S Hakomori
Journal:  Lipids       Date:  1996-09       Impact factor: 1.880

2.  A 2-phase liquid scintillation assay for glycolipid synthetases.

Authors:  A V Hospattankar; N S Radin
Journal:  Lipids       Date:  1981-10       Impact factor: 1.880

3.  The mitochondria-associated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active sphingolipid-specific glycosyltransferases.

Authors:  Dominique Ardail; Iuliana Popa; Jacques Bodennec; Pierre Louisot; Daniel Schmitt; Jacques Portoukalian
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

4.  Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis.

Authors:  S Ichikawa; H Sakiyama; G Suzuki; K I Hidari; Y Hirabayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness.

Authors:  Y Sadahira; F Ruan; S Hakomori; Y Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

6.  A mouse B16 melanoma mutant deficient in glycolipids.

Authors:  S Ichikawa; N Nakajo; H Sakiyama; Y Hirabayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

7.  Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis.

Authors:  K N Burger; P van der Bijl; G van Meer
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.